Joint (NASDAQ:JYNT) Raised to Buy at Wall Street Zen

Key Points

• Wall Street Zen upgraded Joint (NASDAQ:JYNT) from hold to buy, even though the broader analyst view remains cautious with a consensus rating of Reduce and a target price of $18.00.
• Joint reported better-than-expected quarterly results, posting $0.08 EPS versus the $0.03 estimate and revenue of $14.82 million versus $14.50 million expected.
• The stock traded around $8.69, near its 50-day and 200-day moving averages, while insiders and institutional investors have continued to hold significant stakes in the company.

Joint (NASDAQ:JYNT - Get Free Report) was upgraded by Wall Street Zen from a "hold" rating to a "buy" rating in a report released on Saturday.

Other equities analysts also recently issued research reports about the stock. Zacks Research downgraded shares of Joint from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 13th. Weiss Ratings lowered shares of Joint from a "sell (d+)" rating to a "sell (d)" rating in a report on Wednesday. Two equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Joint presently has a consensus rating of "Reduce" and a consensus target price of $18.00.

Joint Stock Up 0.2%

Shares of NASDAQ:JYNT opened at $8.69 on Friday. The company has a market capitalization of $124.44 million, a price-to-earnings ratio of 37.78 and a beta of 1.11. Joint has a 52 week low of $7.50 and a 52 week high of $13.47. The firm has a 50 day moving average of $8.71 and a 200 day moving average of $8.81.

Joint (NASDAQ:JYNT - Get Free Report) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.08 EPS for the quarter, topping analysts' consensus estimates of $0.03 by $0.05. The company had revenue of $14.82 million during the quarter, compared to the consensus estimate of $14.50 million. Joint had a net margin of 5.72% and a return on equity of 6.58%. On average, sell-side analysts expect that Joint will post 0.31 EPS for the current year.

Insider Buying and Selling at Joint

In related news, major shareholder Charles E. Jobson acquired 15,397 shares of the company's stock in a transaction dated Thursday, February 12th. The shares were purchased at an average cost of $8.50 per share, with a total value of $130,874.50. Following the completion of the acquisition, the insider directly owned 1,645,294 shares of the company's stock, valued at $13,984,999. This represents a 0.94% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have acquired 16,354 shares of company stock worth $139,139 over the last 90 days. 30.20% of the stock is owned by insiders.

Institutional Investors Weigh In On Joint

A number of large investors have recently made changes to their positions in JYNT. JCP Investment Management LLC purchased a new stake in shares of Joint during the second quarter valued at $5,526,000. Clayton Partners LLC purchased a new stake in shares of Joint during the fourth quarter valued at $1,652,000. Russell Investments Group Ltd. grew its holdings in shares of Joint by 77.3% during the fourth quarter. Russell Investments Group Ltd. now owns 205,411 shares of the company's stock valued at $1,791,000 after buying an additional 89,526 shares during the last quarter. First Foundation Advisors grew its holdings in shares of Joint by 47.8% during the third quarter. First Foundation Advisors now owns 273,759 shares of the company's stock valued at $2,612,000 after buying an additional 88,486 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new stake in shares of Joint during the fourth quarter valued at $766,000. 76.88% of the stock is owned by hedge funds and other institutional investors.

Joint Company Profile

The Joint Chiropractic, Inc, doing business as Joint NASDAQ: JYNT, is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint's growth strategy centers on partnering with franchisees to expand its network of clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.